Co-Diagnostics IncNASDAQ:CODX
- LAST PRICE1.2400
- TODAY'S CHANGE (%)0.0100 (0.8130%)
- Bid / Lots1.1500/ 10
- Ask / Lots1.3000/ 26
- Open / Previous Close1.2100 / 1.2300
- Day Range
- 52 Week Range
- Volume64,918
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 1398 | 1.21 |
| 09:34 ET | 150 | 1.23 |
| 09:36 ET | 100 | 1.284 |
| 09:38 ET | 388 | 1.2899 |
| 09:39 ET | 10465 | 1.2 |
| 09:41 ET | 2800 | 1.1601 |
| 09:43 ET | 3929 | 1.2351 |
| 10:12 ET | 100 | 1.18 |
| 10:21 ET | 300 | 1.2375 |
| 10:26 ET | 1006 | 1.22 |
| 10:30 ET | 2123 | 1.2385 |
| 10:39 ET | 100 | 1.21 |
| 10:55 ET | 200 | 1.21 |
| 11:00 ET | 844 | 1.22 |
| 11:02 ET | 400 | 1.23 |
| 11:29 ET | 100 | 1.23 |
| 11:40 ET | 979 | 1.2399 |
| 11:44 ET | 4410 | 1.2495 |
| 11:45 ET | 800 | 1.2499 |
| 11:47 ET | 100 | 1.25 |
| 11:49 ET | 100 | 1.2501 |
| 11:51 ET | 100 | 1.25 |
| 11:58 ET | 100 | 1.2401 |
| 12:14 ET | 286 | 1.26 |
| 12:18 ET | 300 | 1.2592 |
| 12:21 ET | 2925 | 1.235 |
| 12:25 ET | 100 | 1.21 |
| 12:38 ET | 100 | 1.24 |
| 12:43 ET | 100 | 1.21 |
| 12:45 ET | 700 | 1.21 |
| 12:50 ET | 200 | 1.21 |
| 01:24 ET | 2000 | 1.2001 |
| 01:30 ET | 100 | 1.2 |
| 01:42 ET | 200 | 1.23 |
| 02:09 ET | 100 | 1.21 |
| 02:26 ET | 100 | 1.23 |
| 02:27 ET | 206 | 1.2036 |
| 02:31 ET | 300 | 1.205 |
| 02:38 ET | 8084 | 1.2299 |
| 02:45 ET | 400 | 1.205 |
| 02:47 ET | 1231 | 1.21 |
| 03:03 ET | 100 | 1.21 |
| 03:05 ET | 100 | 1.22 |
| 03:18 ET | 2623 | 1.215 |
| 03:30 ET | 278 | 1.22 |
| 03:34 ET | 100 | 1.23 |
| 03:36 ET | 100 | 1.22 |
| 03:41 ET | 100 | 1.23 |
| 03:43 ET | 262 | 1.23 |
| 03:50 ET | 4660 | 1.25 |
| 03:52 ET | 120 | 1.2339 |
| 03:54 ET | 669 | 1.231 |
| 03:59 ET | 1546 | 1.24 |
Sep 24, 2024
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan, from 9:30AM ET on Tuesday Sep 24, 2024 by Dow Jones
9:30AM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 5, 2024
Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test, from 9:30AM ET on Thursday Sep 05, 2024 by Dow Jones
9:30AM ET on Thursday Sep 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 41.8M | -1.0x | --- |
T2 Biosystems Inc | 44.2M | -0.2x | --- |
Icecure Medical Ltd | 30.7M | -2.1x | --- |
Neuroone Medical Technologies Corp | 25.6M | -2.0x | --- |
Accelerate Diagnostics Inc | 36.0M | -0.8x | --- |
Medite Cancer Diagnostics Inc | 8.7K | 0.0x | --- |
Company Information
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Contact Information
- Headquarters
- 4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664
- Phone
- 801-278-9769
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Dwight Egan
- President
- Richard Abbott
- Chief Financial Officer, Company Secretary
- Brian Brown
- Chief Operations Officer
- David Nielsen
- Chief Technology Officer
- Christopher Thurston
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $41.8M |
|---|---|
Revenue (TTM) | $9.1M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.87 |
EPS | $-1.27 |
Book Value | $2.75 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -424.64% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
